tiprankstipranks
Sharda Cropchem Ltd. (IN:SHARDACROP)
:SHARDACROP
India Market

Sharda Cropchem Ltd. (SHARDACROP) AI Stock Analysis

5 Followers

Top Page

IN:SHARDACROP

Sharda Cropchem Ltd.

(SHARDACROP)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
₹1,044.00
▲(22.08% Upside)
Action:ReiteratedDate:02/03/26
The score is primarily supported by strong financial performance (growth, profitability improvement, and conservative leverage) and a clearly positive price trend. This is tempered by overbought technical signals that elevate short-term reversal risk and a valuation profile that is fair rather than compelling, with a modest dividend yield.
Positive Factors
Revenue Growth
Sustained ~32% revenue growth indicates expanding market share and strong product uptake across geographies. Over 2-6 months this trend supports continued distributor traction, funding of registrations and market development, and validates the core go-to-market model for scaling sales.
Negative Factors
Asset Utilization
Suboptimal asset utilization implies capital is not being deployed efficiently, which can limit return on invested capital over time. Without improvements, growth could translate into lower incremental returns, constraining ROIC and long-term shareholder value creation.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained ~32% revenue growth indicates expanding market share and strong product uptake across geographies. Over 2-6 months this trend supports continued distributor traction, funding of registrations and market development, and validates the core go-to-market model for scaling sales.
Read all positive factors

Sharda Cropchem Ltd. (SHARDACROP) vs. iShares MSCI India ETF (INDA)

Sharda Cropchem Ltd. Business Overview & Revenue Model

Company Description
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth re...
How the Company Makes Money
Sharda Cropchem makes money mainly by selling crop protection formulations to distributors, retailers, and other channel partners in the agricultural supply chain, with revenue recognized from product sales across its operating geographies. A core...

Sharda Cropchem Ltd. Financial Statement Overview

Summary
Strong overall fundamentals driven by robust revenue and net income growth, healthy gross margin, and prudent leverage (low debt-to-equity). Cash generation is solid with meaningful free cash flow growth, though efficiency improvements are suggested by the noted need for better asset utilization and some margin/capex optimization.
Income Statement
85
Very Positive
Balance Sheet
80
Positive
Cash Flow
78
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue46.72B43.20B31.61B40.45B35.76B23.91B
Gross Profit14.30B12.92B8.18B11.84B10.76B7.55B
EBITDA8.54B6.13B3.43B6.99B7.25B4.96B
Net Income4.52B3.04B318.83M3.42B3.49B2.29B
Balance Sheet
Total Assets49.03B47.25B40.38B43.51B37.43B28.64B
Cash, Cash Equivalents and Short-Term Investments7.83B5.57B3.74B2.13B1.96B1.71B
Total Debt39.57M77.60M183.00M29.65M466.48M807.57M
Total Liabilities22.27B22.24B18.01B21.18B18.30B12.49B
Stockholders Equity26.75B25.01B22.37B22.32B19.12B16.14B
Cash Flow
Free Cash Flow6.05B6.03B692.08M842.03M333.12M151.70M
Operating Cash Flow6.05B6.04B3.41B3.28B2.67B2.46B
Investing Cash Flow-5.24B-5.10B-3.93B-1.45B-2.08B-2.82B
Financing Cash Flow-593.39M-679.32M-369.10M-971.01M-909.56M433.51M

Sharda Cropchem Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price855.20
Price Trends
50DMA
1056.63
Negative
100DMA
947.94
Positive
200DMA
916.09
Positive
Market Momentum
MACD
-21.21
Negative
RSI
55.17
Neutral
STOCH
88.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHARDACROP, the sentiment is Positive. The current price of 855.2 is below the 20-day moving average (MA) of 966.43, below the 50-day MA of 1056.63, and below the 200-day MA of 916.09, indicating a neutral trend. The MACD of -21.21 indicates Negative momentum. The RSI at 55.17 is Neutral, neither overbought nor oversold. The STOCH value of 88.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SHARDACROP.

Sharda Cropchem Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
₹93.27B13.571.02%33.23%107.47%
70
Outperform
₹62.99B12.103.68%-7.53%42.74%
63
Neutral
₹49.92B700.000.92%0.91%18.12%
62
Neutral
₹64.53B11.492.80%15.25%26.49%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹70.51B24.870.93%-3.19%59.25%
60
Neutral
₹30.31B16.520.19%21.67%25.86%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SHARDACROP
Sharda Cropchem Ltd.
1,033.80
582.23
128.94%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
428.70
-35.71
-7.69%
IN:GSFC
Gujarat State Fertilizers & Chemicals Limited
161.95
-13.80
-7.85%
IN:RALLIS
Rallis India Limited
256.70
40.74
18.86%
IN:RCF
Rashtriya Chemicals & Fertilizers Ltd.
127.80
9.10
7.66%
IN:REFEX
Refex Industries Limited
220.95
-184.51
-45.51%

Sharda Cropchem Ltd. Corporate Events

Sharda Cropchem to Hold Virtual Investor Meeting on March 10, 2026
Mar 4, 2026
Sharda Cropchem Ltd. has announced that its officials will participate in an analyst and institutional investor group meeting organized by Arihant Capital on March 10, 2026, to be held virtually between 4:00 p.m. and 5:00 p.m. The discussion will ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 03, 2026